Manufacturing News and Research

RSS

Manufacturing is the production of products across all industries, on a large-scale, using machinery.

Full range of Lab M media for detection and isolation of Listeria shown together for the first time

The document, ‘Listeria solutions… whatever your method’, clearly shows that whichever testing method users subscribe to, whatever the lab size, and whether they prefer dehydrated culture media...

8 May 2015

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

A novel investigational West Nile virus vaccine discovered and developed by scientists at the Oregon National Primate Research Center at Oregon Health & Science University is being evaluated in an NIH-sponsored Phase 1, first-in-human, clinical trial at Duke University. Although several early-stage West Nile virus vaccine clinical trials have been completed to date, no human vaccine has been approved for commercial use.

7 May 2015

Egalet announces business highlights, financial results for first quarter 2015

Egalet Corporation, a fully integrated specialty pharmaceutical company focused on developing, manufacturing and marketing innovative pain treatments, today reported business highlights and financial results for the three months ended March 31, 2015.

7 May 2015

Scientists produce 3D retina tissue structures from iPS cells

Scientists have produced crude 3D tissue structures from induced pluripotent stem (iPS) cells under current good manufacturing practices (cGMP), an important step for eventual large-scale use in human patients.

7 May 2015

Cleaver Scientific launch safe series DNA electrophoresis products

The 'Safe' Series of products from Cleaver Scientific have been designed to make DNA electrophoresis procedures safer, more convenient and more economical to run.

From Cleaver Scientific Ltd 6 May 2015

Medilink UK Awards - The Winners 2015

The best of the UK's Life Sciences and Healthcare Technology sector have been honoured at the 2015 Medilink UK Awards.

6 May 2015

Juniper's total revenues increase 19% to $8.3 million in first quarter 2015

Juniper Pharmaceuticals, Inc., today announced financial results for the three-month period ended March 31, 2015.

6 May 2015

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Transition Therapeutics Inc. today announced its wholly-owned subsidiary, Transition Therapeutics Ireland Limited, has exclusively licensed worldwide rights to a novel small molecule drug candidate ("TT701") from Eli Lilly and Company.

6 May 2015

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen where a newly installed TEM and camera system have enhanced the services provided to users.

5 May 2015

CMC Biologics to supply bulk drug substance for Emergent BioSolutions' IXINITY

CMC Biologics, Inc., a global CMO dedicated to process development and production of biopharmaceuticals for clinical and commercial use, today announced that it will supply bulk drug substance for Emergent BioSolutions' recently FDA-approved product, IXINITY® [coagulation factor IX (recombinant)].

5 May 2015

T cell expansion technology: an interview with Alexander Malykhin, CVPF, University of Pennsylvania

T cells are taken from the patient’s blood and then modified using lentivirus, adenovirus or RNA electroporation.

From Beckman Coulter Life Sciences - Flow Cytometry 5 May 2015

GNC Holdings reports consolidated revenue of $670.2 million for first quarter 2015

GNC Holdings, Inc., a leading global specialty health, wellness and performance retailer, today reported its financial results for the quarter ended March 31, 2015.

30 Apr 2015

HeartWare International's revenue increases 5% to $70.0 million in first quarter 2015

HeartWare International, Inc., a leading innovator of less invasive, miniaturized circulatory support technologies that are revolutionizing the treatment of advanced heart failure, today announced revenue of $70.0 million for the first quarter ended March 31, 2015, a five percent increase compared to $66.5 million in revenue for the same period of 2014.

30 Apr 2015

GE Healthcare’s first Innovation Village in the UK creates international interest from young life science businesses

Edwina Hart, Welsh Minister for Economy, Transport and Science and Kieran Murphy, President and CEO of GE Healthcare Life Sciences, opened the first phase of GE Healthcare’s new campus for growing businesses developing tools and technologies for the global life sciences industry on 27th April.

29 Apr 2015

Sangamo BioSciences to present data on ZFP Therapeutic platform at ASGCT meeting

Sangamo BioSciences, Inc. announced that data from clinical, preclinical and research-stage programs focused on the development of ZFP Therapeutics will be presented at the 18th Annual Meeting of the American Society of Gene and Cell Therapy

29 Apr 2015

Two UWM sensors offer protection against threat of contaminated water supplies

About 13.2 million households in the United States obtain their water from private wells, a method that offers no assurances of the water's quality. Testing private wells can be expensive and results can take weeks.

29 Apr 2015

IDT opens molecular biology R&D facility in Redwood City

Already the world’s leader in custom nucleic acid synthesis, Integrated DNA Technologies (IDT) is capitalizing on its expertise to deliver a broader range of validated molecular biology products. Research and development for these products will now be performed in a newly built facility in Redwood City, California.

From Integrated DNA Technologies 28 Apr 2015

Stempeutics Research granted process patent in China for novel stem-cell based drug Stempeucel

Stempeutics Research, a group company of Manipal Education and Medical Group and a Joint Venture with Cipla Group, announced today that the State Intellectual Property Office of China granted a process patent for its novel stem-cell based drug Stempeucel.

28 Apr 2015

Resverlogix, Hepalink announce equity investment and license agreement for RVX-208

Resverlogix Corp. today announced that it has entered into a Framework Agreement which sets forth the principal business terms for an equity investment and a license of RVX-208, for all indications, to Shenzhen Hepalink Pharmaceutical Co., Ltd. for China, Hong Kong, Taiwan and Macau (the "Territories").

27 Apr 2015

Haemonetics' revenue for fourth quarter fiscal 2015 down 6%

Haemonetics Corporation today reported revenue for the fourth quarter fiscal 2015 of $226.5 million, down 6%. Excluding currency impact, revenue was down 4% in the quarter. The Company reported a fourth quarter GAAP net loss of $2.9 million or $0.06 per share.

27 Apr 2015

Manufacturing News and Research

Further Reading

Full range of Lab M media for detection and isolation of Listeria shown together for the first time

NIH-sponsored Phase 1 clinical trial evaluates novel investigational West Nile virus vaccine

Egalet announces business highlights, financial results for first quarter 2015

Scientists produce 3D retina tissue structures from iPS cells

Cleaver Scientific launch safe series DNA electrophoresis products

Medilink UK Awards - The Winners 2015

Juniper's total revenues increase 19% to $8.3 million in first quarter 2015

Transition Therapeutics acquires worldwide rights from Lilly to develop, commercialize TT701

Deben reports on the work of the Microscopy & Histology Core Facility at the University of Aberdeen

CMC Biologics to supply bulk drug substance for Emergent BioSolutions' IXINITY

T cell expansion technology: an interview with Alexander Malykhin, CVPF, University of Pennsylvania

GNC Holdings reports consolidated revenue of $670.2 million for first quarter 2015

HeartWare International's revenue increases 5% to $70.0 million in first quarter 2015

GE Healthcare’s first Innovation Village in the UK creates international interest from young life science businesses

Sangamo BioSciences to present data on ZFP Therapeutic platform at ASGCT meeting

Two UWM sensors offer protection against threat of contaminated water supplies

IDT opens molecular biology R&D facility in Redwood City

Stempeutics Research granted process patent in China for novel stem-cell based drug Stempeucel

Resverlogix, Hepalink announce equity investment and license agreement for RVX-208

Haemonetics' revenue for fourth quarter fiscal 2015 down 6%

Exploring the G:Box and for high-quality imaging

Shaping the Future of Neuroscience: A Conversation with Atlas Antibodies on the MolBoolean™ and the Impact of SfN 2024

How the Arts Reshape Brain Function: Susan Magsamen on the Future of Neuroaesthetics

Latest Life Science News